Chemo-embolization for Head and Neck Cancer

NCT04595981 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No staff or funding to do the study.

Conditions

SCCHN
Squamous Cell Carcinoma

Interventions

DRUG: Cisplatin

Sponsor

University of Alabama at Birmingham